Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Nippon Shinyaku Gets EU Orphan Tag for Myelofibrosis Med
August 9, 2023
- Otsuka Unit Astex, Merck Expand Drug Discovery Alliance
August 9, 2023
- Astellas Puts Up US$50 Million for CAR-T Player Poseida
August 9, 2023
- Astellas Set to Cut Development Time with Cell Culture Robot, Eyes 4 Billion Yen Profit per Product
August 9, 2023
- Shipment Restrictions Now Hit All Versions of Mounjaro in Japan
August 8, 2023
- Daiichi Sankyo to Shutter R&D Subsidiary in Tokyo in Group Rejig
August 8, 2023
- Iveric Bio’s AMD Drug Approved in US, Launch Set for This Month: Astellas
August 8, 2023
- Global PIII Study for Zipalertinib Begins for 1st Line NSCLC: Taiho
August 8, 2023
- Nippon Shinyaku’s DMD Therapy Gets Orphan Tag in US
August 8, 2023
- Kyowa Kirin Chief Admits Difficulties in Trial Design Felt with Dumped Kidney Disease Med
August 7, 2023
- Wakamoto Seeks to Add New Manufacturer for MaQaid amid Supply Woes
August 7, 2023
- Mitsubishi Tanabe Aims to Maximize Value of Mounjaro through Synergies with Other Products
August 4, 2023
- Kyowa Kirin’s 6-Month Sales Up 7.5% as Global Brands Log Positive Growth
August 4, 2023
- Rakuten Medical Gears Up for Global Pitch on Photoimmunotherapy: Chairman
August 4, 2023
- Lonsurf-Bevacizumab Snags US Approval for Colorectal Cancer: Taiho
August 4, 2023
- Opdivo Tops Japan Sales Ranking for 19 Months on End: Encise
August 4, 2023
- Eisai Sees Positive Shift in US Market for Leqembi after Full Approval: Exec
August 3, 2023
- Sumitomo to Focus on 3 Core Products in North America to Overcome Latuda Patent Cliff: President
August 3, 2023
- Mitsubishi Tanabe’s Q1 Sales Up 3.8% on Back of Bullish Oral Radicava Sales in US
August 3, 2023
- Pfizer’s Bivalent COVID Vaccines Approved for Primary Series in Japan
August 3, 2023
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…